BEST SPAC I Acquisition (BSAAR) EBITDA (2025 - 2026)
BEST SPAC I Acquisition (BSAAR) posted quarterly EBITDA of -$145134.0 for Q1 2026, down 256.88% year-over-year from $92515.6 in Q1 2025, and down 55.16% quarter-over-quarter from -$93540.0 in Q4 2025.
Powered by 
Analysis
BEST SPAC I Acquisition (BSAAR) EBITDA (2025 - 2026) Analysis & Trends
BEST SPAC I Acquisition's EBITDA history runs 2 years deep, the most recent figure standing at -$145134.0 for Q1 2026.
- In Q1 2026, EBITDA fell 256.88% year-over-year to -$145134.0; the TTM figure through Mar 2026 stood at -$755835.0 (changed N/A YoY), while the FY2025 annual figure was -$651369.0, down 21612.3% from the prior year.
- EBITDA for Q1 2026 stood at -$145134.0, down from -$93540.0 in the prior quarter.
- The five-year high for EBITDA was -$40668.0 in Q1 2025, with the low at -$423606.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | -8,222.00 |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - | - |
| 3 | Armada Acquisition | 666.54 Mn | 666.49 Mn | - | -503,862.00 |
| 4 | Fifth Era Acquisition Corp I | 657.23 Mn | 657.23 Mn | - | -808,001.00 |
| 5 | Andretti Acquisition | 656.30 Mn | 656.30 Mn | - | -167,765.00 |
| 6 | Oxley Bridge Acquisition | 652.74 Mn | 652.74 Mn | - | -150,114.00 |
| 7 | Drugs Made In America Acquisition | 647.83 Mn | 647.83 Mn | - | -112,227.00 |
| 8 | Launch Two Acquisition | 621.00 Mn | 621.00 Mn | - | -1.01 Mn |
| 9 | Launch One Acquisition | 620.42 Mn | 620.42 Mn | - | -593,448.00 |
| 10 | BEST SPAC I Acquisition | 417,890.00 | 417,890.00 | - | -124,997.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -124,997.00 |
| Mar 31, 2026 | -145,134.00 |
| Dec 31, 2025 | -93,540.00 |
| Sep 30, 2025 | -423,606.00 |
| Jun 30, 2025 | -93,555.00 |
| Mar 31, 2025 | -40,668.00 |